News

€1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project.

Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.

The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer.

Researchers have identified a substance released by pancreatic cancer cells that protects them from attack by immune cells called macrophages

Metastatic spread of tumor cells from one location in the body to another is the cause of 90 percent of cancer-related deaths.

When choosing their preferred treatment, people with chronic lymphocytic leukemia (CLL) place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for a reduced risk of serious adverse events according to a new study.

After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer.

University of Virginia researchers are working to study this variability and find an end-around method to stop triple-negative breast cancer, by seeking out unknown or little-understood routes toward shutting down uncoordinated growth.

Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.

CRISPR-edited T-cells could be a thousand times better at seeing and killing cancer than T-cells prepared using the current methodology.